Concurrent and predictive validities of the Bayley Motor Scale and the Peabody Developmental Motor Scales were examined by administering both tests to 23 full-term and 21 healthy premature infants at 12, 15, and 18 months of age. For both groups, a correlation analysis of age-equivalent scores indicated Bayley scores had good to high correlation with Peabody gross motor scores (range, r = .78 to r = .96) and unacceptable correlation with Peabody fine motor scores (range, r = .20 to r = .57). When results were reported using standardized quotients, mean Bayley quotients for the full-term infant group were significantly higher than Peabody gross motor quotients. Prediction of motor development at 18 months of age was limited (range, r = .25 to r = .60), with the exception of Peabody fine motor scores for the premature infant group (r = .75). This study provides evidence of concurrent validity between Bayley motor and Peabody gross motor age-equivalent scores, and it suggests the need for further testing, using separate assessments of gross motor and fine motor ability, to determine motor development at later ages.
Many pediatric physical therapists are involved in the evaluation of full-term and premature infants who are at risk because of a delay or disorder in motor development. An important aspect of the physical therapist's evaluation of the high-risk infant is the administration of motor assessments that provide information pertinent to determining developmental status and making recommendations for management. When functional ability is documented, the results of motor development assessments complement findings obtained from the evaluation of muscle tone, reflexes, righting reactions, and equilibrium responses. Knowledge of an infant's functional ability is helpful particularly in interpreting the significance of questionable findings for muscle tone and automatic motor responses, results that may be transient or may become less pronounced over time. 1, 2 The reliance on developmental testing to assist in making clinical decisions, however, entails the responsibility of selecting assessment methods that yield reliable and valid measurements of motor development.
Conclusions about an infant's motor development level or developmental quotient should be based only on the results of an assessment involving 1) a standardized administration procedure and 2) a normative sample that reflects the cultural background of the infants for whom the assessment is being used. 3 The Motor Scale of the Bayley Scales of Infant Development 4 is, perhaps, the most widely used standardized motor scale that was normalized using American infants. Normalized between 1958 and 1962 on 1,262 infants aged 2 to 30 months, the Bayley Motor Scale contains 81 items scored on a pass-fail basis, 69 of which measure gross motor behaviors. Testing takes 15 to 20 minutes to complete, and results are expressed either by a standardized psychomotor developmental index (PDI) or by an age-equivalent score. The Bayley Motor Scale has been used in the research of developmental outcomes for high-risk infants, particularly premature infants, 5, 6 and to measure the effects of treatment in infants with Down syndrome. 7 Although widely used, the Bayley Motor Scale contains a small number of items for each level of development and omits stages in the motor developmental sequence. For example, it contains no items for running or kicking, and a single item incorporates all methods of prewalking progression (eg, creeping, crawling, hitching on buttocks). The Bayley Motor Scale, therefore, does not provide an in-depth motor assessment nor does it delineate gross motor and fine motor development.
In contrast to the Bayley Motor Scale, the revised Peabody Developmental Motor Scales 8 have been standardized recently on a nationwide sample of 617 infants and children aged 1 through 83 months and consist of separate Gross Motor and Fine Motor Scales, allowing for a more detailed assessment of motor development. The Gross Motor Scale is divided into five skill categories (reflexes, balance, nonlocomotor, locomotor, and receipt and propulsion of objects), and the Fine Motor Scale is divided into four skill categories (grasping, hand use, eye-hand coordination, and manual dexterity). The Gross Motor Scale contains 10 items at each age level, and the Fine Motor Scale contains either 6 or 8 items at each age level. Test items are scored on a 0-to 2-point scale with a score of 1 indicating partial suc-RESEARCH cess. Both scales can be administered in 45 to 60 minutes, and they present test results in a variety of ways, including a standardized developmental motor quotient (DMQ) and an age-equivalent score. Based on the greater number of test items and the partial credit an infant receives for emerging skills, the Peabody scales are more sensitive potentially to change in motor development than is the Bayley Motor Scale. The ability to measure small changes in motor development is an important quality of an assessment tool that is used to monitor progress in infants demonstrating delays in development.
Although the more recently normalized Peabody Developmental Motor Scales offer potential advantages for testing high-risk infants, information on concurrent validity is necessary to determine whether Peabody test results are comparable to results obtained with the more established Bayley Motor Scale. The purpose of this study was to compare concurrent and predictive validities of the Bayley Motor Scale and the Peabody Developmental Motor Scales by administering both tests to groups of full-term and premature infants at 12, 15, and 18 months of age. Concurrent validity is concerned with the correspondence between a test's results and the results obtained with a previously available test that is considered reliable and valid. Predictive validity, as it pertains to this study, indicates the extent to which motor development can be predicted from knowledge of prior test performance. 9 Folio and Fewell concluded that concurrent validity exists for the Bayley Motor Scale and the Peabody Developmental Motor Scales on the basis of statistically significant (p = .02) correlation coefficients of .36 (Bayley Motor Scale and Peabody Gross Motor Scale) and .37 (Bayley Motor Scale and Peabody Fine Motor Scale). 8 When validity is investigated with the correlation analysis, however, the magnitude of the correlation coefficient is the most critical factor; a correlation coefficient below .60 is not considered to be acceptable, regardless of the level of statistical significance. 10 I also investigated the concurrent validity of the Bayley Motor Scale and the Peabody Developmental Motor Scales by examining the magnitude of the correlation coefficients and the mean scores obtained for each assessment tool. Additionally, by testing each infant three times, I determined the ability of each assessment tool to predict motor development over a sixmonth period and to measure change in motor development. The clinical implications of the results of my study are emphasized in this article.
METHOD

Subjects
The subjects were 23 full-term infants (13 male, 10 female) and 21 premature infants (12 male, 9 female) who were born in 1982 at one of four Boston hospitals. Data were collected as part of a longitudinal study of how to account for gestational age at birth when evaluating premature infant motor development. 11 Approval for the study was granted by each hospital's human subjects committee, and a consent form was signed by a parent of each infant. The full-term infants had an uncomplicated neonatal history and no medical problems during the first year. Based on neonatal history and health during the first year, the premature infants were considered to be at low risk for a disorder in motor development. Premature infants selected for the study did not have any of the following medical problems that can contribute to a poor developmental outcome 12 : neonatal asphyxia, respiratory complications (infants received a maximum of three days of low-concentration, supplemental hood oxygen while in the incubator), seizures, intracranial hemorrhage, congenital anomalies, or orthopedic deformities. The premature group had a mean gestational age at birth of 31.3 weeks (s = 1.0) and a mean birth weight of 1,602.5 g (s = 270.6).
Procedure
The Bayley Motor Scale and the Peabody Developmental Motor Scales were administered to all infants within a twoweek period after their 12-month, 15-month, and 18-month birthdays. When premature infants are tested, developmental quotients commonly are based on adjusted age, which accounts for gestational age at birth. 13 (An infant born two months prematurely and tested at 12 months' chronological age would have an adjusted age of 10 months.) To compare this practice for the two assessment tools examined in this study, I based the developmental quotients on adjusted age for the premature infants.
The mean adjusted ages of the premature group were 10, 13, and 16 months for each successive test session.
Before the testing, I established interrater reliability by testing 10 infants not included in the study, and a second therapist independently scored each infant's performance. Reliability was determined by computing the percentage of agreement on items actually tested. The mean percentages of agreement were 90.0 for the Bayley Motor Scale, 87.5 for the Peabody Gross Motor Scale, and 90.8 for the Peabody Fine Motor Scale.
I administered all tests, which were performed in each infant's home with at least one parent present. A typical test session required one hour to complete. All test items were administered and scored according to the standardized procedures contained in the test manuals. Neither the Bayley nor the Peabody scales require that items be administered in a specific order; therefore, the following procedures were implemented to improve data collection. Items from the two assessment tools were interspersed and administered by developmental position (gross motor) or materials presented (fine motor). This procedure minimized the time required for testing and, thus, optimized the infants' performances. Several motor behaviors on the two scales are similar, differing only in criteria for a passing score. For example, item 46 ("Walks alone") on the Bayley Motor Scale requires an infant to take 3 independent steps, whereas item 66 ("Walking") on the Peabody Gross Motor Scale requires the infant to take 4 or 5 independent steps. Consequently, motor behaviors common to both scales were scored simultaneously using the specific criteria for each scale. This procedure eliminated unnecessary repetition and also ensured that differences in test results were not attributable to variability in an infant's performance.
Data Analysis
Each infant's age-equivalent scores and standardized motor quotients were calculated for both the Bayley Motor Scale and the Peabody Developmental Motor Scales. The Bayley PDI is determined for age intervals of 1 month. The Peabody DMQ is determined for age intervals of varying length. The age levels that pertain to this study are 8
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Concurrent and predictive validities were examined using correlation analysis, statistical analysis of mean scores, and change in mean age-equivalent scores. Correlation analysis was performed using the Pearson product-moment correlation coefficient. The magnitude of each correlation coefficient was interpreted using criteria for examining validity proposed by Meyer 10 (Tab. 1). Analysis of mean scores is essential for judging concurrent validity. Regardless of the magnitude of the correlation coefficients, the clinical interpretation of the results would be affected if mean scores were significantly higher or lower for one of the assessment tools. The significance of differences in mean Bayley motor and Peabody gross motor scores was examined for each group by a 2 × 3 (test × age) mixed analysis of variance (ANOVA) with repeated measures on age. For each assessment tool, the significance of the age-related changes in each group's mean ageequivalent scores was tested by a onefactor ANOVA for repeated measures, and significant age effects were analyzed further by the Newman-Keuls method of multiple comparisons. The .05 probability level was used to test for statistical significance.
RESULTS
Concurrent Validity of AgeEquivalent Scores
Correlation analysis indicated good to high correlation between Bayley motor and Peabody gross motor age-equivalent scores for both groups with correlation coefficients ranging from .78 to .96 (Tab. 2). The correlation between Bayley motor and Peabody fine motor ageequivalent scores was not acceptable for either group; only the correlation coefficient for the premature group at 15 months of age was greater than .50. Mean Bayley motor and Peabody gross motor age-equivalent scores differed for the premature group by no greater than 0.4 months and for the full-time group by 0.2 months, 0.8 months, and 1.5 months, respectively, for the three test ages (Tab. 3). For each group, the ANOVA indicated that mean age-equivalent scores for the two assessment tools did not differ significantly (full-term 
Prediction of Age-Equivalent Scores
Predictive ability of 18-month Bayley motor and Peabody gross motor and fine motor age-equivalent scores from 12-month scores was unacceptable with the exception of the premature group's Peabody fine motor scores (r = .75) and the full-term group's Peabody gross motor scores (r = .60) (Tab. 6). For the 3-month intervals, predictive ability of Peabody gross motor scores ranged from unacceptable to high (range, r = .58 to r = .85), whereas predictive ability of Bayley motor scores ranged from unacceptable to fair (range, r = .59 to r = .70). The predictive ability of 15-month Peabody fine motor age-equivalent scores from 12-month scores was good for the premature group (r = .77) and poor for the full-term group (r = .65). The predictive ability of 18-month Peabody fine motor scores from 15-month scores was unacceptable for both groups.
Change in Mean Age-Equivalent Scores
Between each test age, the full-term and premature infants made from 2.8 to 4.1 months' gain in mean Bayley motor age-equivalent scores, from 2.8 to 3.4 months' gain in mean Peabody gross motor age-equivalent scores, and from 2.1 to 3.6 months' gain in mean Peabody fine motor age-equivalent scores, gains that were significant for each group (Tab. 3). For the full-term group, the age effect was well above the level required for statistical significance for the Bayley Motor Scale (F = 102.5; df = 2,44; p < .001), the Peabody Gross Motor Scale (F = 232.7; df = 2,44; p < .001), and the Peabody Fine Motor Scale (F = 155.9; df = 2,44; p < .001). Similarly, for the premature group, the age effect was highly significant for the Bayley Motor Scale (F = 121.8; df = 2,40; p < .001), the Peabody Gross Motor Scale (F = 137.7; df = 2,40; p < .001), and the Peabody Fine Motor Scale (F = 214.2; df = 2,40; p < .001). For each assessment tool, multiple comparison tests revealed that mean ageequivalent scores were significantly higher at each successive test age (p < .01). The mean age-equivalent scores of the full-term group generally were 2 to 3 months' higher than those of the premature group, an anticipated finding considering that the premature infants were born an average of 2 months prematurely.
DISCUSSION
The results provide evidence of concurrent validity for Bayley motor and 
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Peabody gross motor age-equivalent scores. Correlation analysis revealed that good to high correlation existed between age-equivalent scores and that mean age-equivalent scores for the two assessments were not significantly different. The difference between mean Bayley motor and Peabody gross motor age-equivalent scores for the full-term group, however, increased at each successive test age. The full-term group's mean age-equivalent score of 20.6 months at 18 months of age suggests that the Bayley Motor Scale may overestimate motor development at certain age levels. Both groups of infants made significant gains in mean Bayley motor and mean Peabody gross motor and fine motor age-equivalent scores during the 6-month period. The infants' rate of development supports the concepts that motor development is orderly and sequential and that motor abilities of healthy infants increase with age, implying that both Bayley and Peabody ageequivalent scores provide valid measures of age-related change in motor development.
The correlation results for gross motor development are more favorable than those reported by Folio and Fewell
8
; however, the Peabody test manual does not describe the subjects tested or present mean scores, preventing a comparison of results. The low correlation between Bayley PDIs and Peabody gross motor DMQs (r = .36) reported by Folio and Fewell may reflect, in part, their sample having included infants under 1 year of age who were administered both gross motor and fine motor items from the Bayley Motor Scale. Conversely, because the Bayley Motor Scale contains no fine motor items above the 8.9-month age level, the infants in this study almost exclusively were administered gross motor items from the Bayley Motor Scale. The Bayley Motor Scale, therefore, served as a measure of gross motor development. Consequently, the correlations between the Bayley motor and Peabody gross motor scores were higher than the correlations between the Bayley motor and Peabody fine motor scores. The unacceptable correlation between the Bayley motor and Peabody fine motor scores reported by Folio and Fewell 8 and in this study suggests that performance on gross motor items is not related strongly to performance on fine motor items. Therapists, therefore, are encouraged to perform separate assessments of gross motor and fine motor development.
The significantly higher mean Bayley PDIs achieved by the full-term group pose a threat to concurrent validity when Bayley motor and Peabody gross motor results are expressed using standardized quotients. The difference in mean quotients for the two assessment tools may be attributable to the method used to determine standardized quotients for the Peabody Developmental Motor Scales. The Bayley PDI is based on age-level intervals of 1 month, whereas the Peabody DMQ is based on variable and wide-ranging age levels. The DMQ for a 12-month-old infant, for example, is based on the performance of infants in the normative group whose ages ranged from 12 to 14 months. In this study, the ages of the full-term infants corresponded to the youngest month of each age level for each test session and, therefore, their lower mean DMQs and inability to achieve a mean DMQ of 100 are not surprising.
The method of determining standardized quotients for the Peabody scales also presents a problem when testing premature infants. This problem was avoided in this study by the selection of chronological test ages that corresponded to the youngest month of an age level. Depending on the chronological age of the premature infant, adjusting age to account for gestational age at birth may not change the DMQ. For example, an infant born 2 months prematurely and tested at 14 months' chronological age would have an adjusted age of 12 months. The DMQ would be determined for the 12-through 14-month age level and, therefore, would be identical for both chronological and adjusted ages. In contrast, the Bayley PDI would be higher when determined for adjusted age, as compared with chronological age.
The findings of this study indicate that, when results are expressed as standardized quotients, decisions regarding an infant's motor developmental status could differ depending on whether the Bayley Motor Scale or Peabody Gross Motor Scale is used. Standardized DMQs are advantageous for determining whether an infant's motor development is within age expectations or for presenting research findings. Alternately, age-equivalent scores are more meaningful for infants whose motor development is below the normal range of variability. Age-equivalent scores also provide a clearer indication of functional ability than do standardized DMQs. Therapists may find that ageequivalent scores are more appropriate than standardized quotients for clinical use and, thus, avoid the problem of interpreting differences between the standardized quotients obtained with the Bayley Motor Scale and the Peabody Gross Motor Scale.
Neither Bayley nor Peabody 12-month age-equivalent scores effectively predicted motor development at 18 months of age in this study. Correlation coefficients were higher between successive 3-month intervals, indicating that the ability to predict motor development decreases as the timespan involved increases. The variability associated with infant development and differences in the motor competencies required for success at older age levels probably are limiting factors in attempting to make predictions. For the Bayley Motor Scale or the Peabody Developmental Motor Scales to be of value in predicting development at older ages, correlation coefficients of .75 or greater must be demonstrated between scores obtained over periods of time when major changes in motor ability occur (eg, at 3 and 12 months of age or at 12 and 24 months of age). Until evidence of predictive validity is demonstrated, the Bayley Motor Scale and the Peabody Developmental Motor Scales should be used only to provide current information on the motor ability of an infant relative to the performance of the normative group. Repeated testing is necessary to determine development at older ages.
This study suggests that therapists may choose between the Bayley Motor Scale and the Peabody Developmental Motor Scales when results are reported using age-equivalent scores. The Bayley Motor Scale may be the preferred assessment tool when time is restricted, such as in infant follow-up clinics. When evaluation of both gross motor and fine motor development is desired, however, the Peabody Developmental Motor Scales may be more appropriate than the Bayley Motor Scale. Additionally, the Peabody Developmental Motor Scales may be selected when a more thorough evaluation of motor development is indicated. The Peabody scales also potentially are able to document RESEARCH development over relatively short periods of time and measure response to physical therapy intervention.
In this study, changes in mean ageequivalent scores of healthy full-term and premature infants were highly significant over a six-month period for both the Bayley Motor Scale and the Peabody Developmental Motor Scales. These findings, however, may not be generalizable to infants with identified delays or disorders in motor development. Research with the experimental edition of the Peabody Developmental Motor Scales 14 revealed statistically significant treatment effects for a group of children with delayed development 15 and a group of severely and profoundly retarded nonambulatory children. 16 The results of these two studies suggest that the Peabody scales are an appropriate assessment tool for children with delays or disorders in motor development. The latter study especially is important because of the low levels of function in the children tested. A criticism of normreferenced motor scales is that they are not suitable for evaluating short-term responses to treatment in nonambulatory children, particularly children with cerebral palsy. 17 Further research to examine the validity of using the Bayley Motor Scale and the Peabody Developmental Motor Scales to document developmental changes in high-risk infants and infants with identified delays or disorders in motor development may aid physical therapists in the proper selection of evaluation tools.
CONCLUSIONS
This study provides evidence of concurrent validity for the Bayley Motor Scale and the Peabody Gross Motor Scales on the basis of age-equivalent scores. The results also indicate that the Bayley Motor Scale and the Peabody Developmental Motor Scales effectively measure age-related change in motor development for healthy full-term and premature infants but do not predict motor development at later ages. When the data are based on standardized quotients, however, problems may exist in the clinical interpretation of the Peabody DMQ, presenting a threat to concurrent validity. This study suggests that therapists should perform separate assessments of gross motor and fine motor development and that repeated testing is necessary to determine motor development at later ages. Further research is needed to determine the validity of using the Bayley Motor Scale and the Peabody Developmental Motor Scales to measure change in motor development for infants with identified delays or disorders in motor development.
